# Handoff Report: MicroDefend Multi-Tab Lymphatic & Hematopoietic Expansion

**Date**: 2026-11-10T02:20:00Z  
**Agent**: Project Orchestrator (`orchestrator_2`)  
**Mission**: 擴充 MicroDefend 微觀人體防線模擬器，新增分頁以視覺化呈現淋巴循環（輸入淋巴管、淋巴結內部免疫反應、淋巴總管匯流至靜脈）以及骨髓造血與免疫記憶事件。  
**Status**: **COMPLETED (Gate Result: PASS)**  

---

## 1. Observation

1. **Architecture & Scope**:
   - Built a 4-tab interactive micro-circulation simulator expanding the original single-page defense model:
     - **Tab 1: 第一道與第二道防線 (組織微循環與發炎反應)**: Original microcirculation scene with capillary bed, arteriole/venule, extravasation, phagocytosis, and initial lymphatic capillary at bottom right (`x=1000, y=248..288`).
     - **Tab 2: 淋巴結專一性免疫反應 (輸入淋巴管 ➔ 濾泡生發中心 ➔ 輸出淋巴管)**:
       - Spatial continuity: Afferent lymphatic vessel arrives at `x=0, y=248..288`, directly matching Page 1's exit.
       - Complete anatomical compartmentalization: subcapsular sinus, trabeculae, cortical follicles with active germinal centers (centroblasts/centrocytes), paracortex (T-cell zone), medullary cords and sinus, and efferent lymphatic vessel exiting the hilum with valve.
       - Physiological cascade: dendritic cell antigen presentation (MHC-II to TCR), CD4+ helper T cell activation (IL-2/IL-4 cytokines), B cell clonal expansion, plasma cell differentiation, and high-affinity antibody secretion into efferent lymph.
     - **Tab 3: 淋巴總管與靜脈匯流 (左靜脈角、雙葉靜脈瓣膜與層流血液動力學)**:
       - Left venous angle anatomy: junction of left subclavian vein and internal jugular vein forming the superior vena cava.
       - Thoracic duct confluence with functional terminal bicuspid venous valves preventing retrograde blood reflux during pulsatile cardiac cycles.
       - Hemodynamics & styling fidelity: Endothelial walls, rapid laminar shear profile (peak velocity in vessel center, lower near endothelia), RBC biconcave discs with rotational tumbling, and rolling WBCs matching Page 1 visual tokens.
     - **Tab 4: 骨髓造血與免疫記憶 (長壽漿細胞工廠、造血幹細胞分化產線與嗜中性球儲存庫)**:
       - Marrow niche anatomy: Trabecular bone ivory matrix, sinusoidal capillaries with fenestrated transcellular endothelial pores (Pores 1–4).
       - Long-Lived Plasma Cell (LLPC) factory: Resident in perivascular CXCL12-rich stromal niches, continuously secreting basal IgG antibodies to sustain systemic antibody titers (closing the immunological loop with Page 1).
       - Hematopoietic Stem Cell (HSC) pipeline: Asymmetric self-renewal, multipotent progenitors (MPP), common myeloid (CMP) and lymphoid (CLP) lineages.
       - B cell development pipeline: Pro-B ➔ Pre-B ➔ Immature B ➔ Naive B cell transendothelial migration through Pore 1 into sinusoids.
       - Neutrophil maturation pipeline: Myeloblast ➔ Promyelocyte ➔ Myelocyte ➔ Metamyelocyte ➔ Band cell ➔ Segmented neutrophil; massive storage pool with acute G-CSF mobilization and pore transmigration.
     - **Interactive UI Controls & Lifecycle Hygiene (All Tabs)**:
       - Modular control panels for each tab supporting pathogen injection, cell reaction triggers, state labels, and simulation speed adjustments (0.5x, 1x, 2x, pause/play).
       - Active-tab simulation gating (only active tab runs rendering and physics updates).
       - Zero-allocation SVG object pooling: Pre-instantiated or lazy-expanded pools with hidden reuse (`display: none`), maintaining $\le 1$ node net delta in steady-state operation.
       - Zero JavaScript console errors or unhandled exceptions across all operations.

2. **Verification & Audit Results**:
   - **Automated Regression Suite (`test_microdefend_e2e.py`)**: 15 / 15 tests passed (100%).
   - **Node.js Chrome DevTools Protocol E2E Suite (`test_cdp_e2e.js`)**: 18 / 18 tests passed (100%).
   - **Adversarial Stress Test Suite (`test_microdefend_adversarial.js`)**: 25 / 25 checks passed (100%), including 60 rapid tab transitions, 0.1x to 5.0x simulation speeds and oscillation, burst pathogen injections, 8 viewport resolutions (320px to 2560px), and steady-state DOM stabilization.
   - **Biological Invariant Suite (`test_challenger2_invariants.py`)**: 12 / 12 tests passed (100%).
   - **Live CDP Dynamic Invariant Suite (`test_challenger2_cdp.js`)**: 5 / 5 tests passed (100%).
   - **Forensic Integrity Audit (`auditor_1`)**: **CLEAN (0 violations)**. 0 hardcoded test mocks, 0 external JS dependencies, genuine procedural SVG vector mathematics throughout.
   - **Remediation of Invariant 3**: Transendothelial pore distance oscillation trap resolved via state-latching in `microDefend/script.js` (lines 7994–8026 and 8072–8104). Verified 100% successful intravasation into sinusoidal blood.

---

## 2. Logic Chain

1. **Dual Track Architecture**:
   - The project followed the Dual Track model. The E2E Testing Track independently mapped requirements from `ORIGINAL_REQUEST.md` to design an automated test suite across Tiers 1–4 before implementation began.
   - The Implementation Track implemented Milestones M1, M2, M3, and M4 sequentially, adhering to defined spatial and lifecycle interface contracts.
2. **Interface Contracts & Mathematical Alignment**:
   - Page 1 capillary exit and Page 2 afferent lymphatic vessel meet at identical coordinate bounds (`y = 248..288`, center `y = 268`) with matching vector orientation (`vx > 0, vy = 0`), creating seamless visual continuity.
   - Page 4's basal IgG production connects physiologically with Page 1's memory immunity, showing how long-lived plasma cells in bone marrow sustain systemic antibody defenses.
3. **Adversarial Hardening & Forensic Verification**:
   - Reviewer 1 & Reviewer 2 approved biological completeness and system hygiene.
   - Challenger 1 pushed extreme stress conditions (60 rapid switches, 0.1x–5.0x speed oscillation, burst clicks, 8 viewports).
   - Challenger 2 detected a subtle kinematic oscillation trap where pore entrance distance checks were interrupting active cell transmigration.
   - Worker remediation resolved the flaw with state latching (`if (sn.squeezing)` / `else if (bc.squeezing)`), confirmed by both static analysis and live Chrome DevTools Protocol execution.
   - Forensic Auditor verified all implementations are genuine procedural algorithms without facade mocks or open-source plagiarism.

---

## 3. Caveats

- Simulation is optimized for standard desktop, laptop, and tablet viewports. Ultra-narrow viewports (<320px) retain proportional SVG scaling via declarative `viewBox="0 -65 1000 565"`, but text labels may appear compact.
- The simulation runs client-side in standard modern web browsers supporting SVG 1.1 and ECMAScript 2020. No server backend or external runtime is required.

---

## 4. Conclusion

All acceptance criteria set forth in `ORIGINAL_REQUEST.md` have been fully met and empirically validated. The gate check for Milestone 5 passed unconditionally with APPROVE verdicts from both reviewers and both challengers, and a CLEAN verdict from the forensic auditor.

---

## 5. Verification Method

To independently verify the entire solution, run the following commands from the repository root:

```powershell
# 1. Run Python 4-Tier Automated Regression Suite (15/15 PASS expected):
& "C:\Users\user\miniconda3\python.exe" tests/test_microdefend_e2e.py

# 2. Run Biological Invariant Verification Suite (12/12 PASS expected):
& "C:\Users\user\miniconda3\python.exe" tests/test_challenger2_invariants.py

# 3. Run Node.js Chrome DevTools Protocol E2E Suite (18/18 PASS expected):
& "C:\Users\user\AppData\Local\ms-playwright-go\1.57.0\node.exe" tests/test_cdp_e2e.js

# 4. Run Node.js CDP Adversarial Stress Suite (25/25 PASS expected):
& "C:\Users\user\AppData\Local\ms-playwright-go\1.57.0\node.exe" tests/test_microdefend_adversarial.js

# 5. Run Live CDP Browser Dynamic Clearing Suite (5/5 PASS expected):
& "C:\Users\user\AppData\Local\ms-playwright-go\1.57.0\node.exe" tests/test_challenger2_cdp.js
```
